Bright Minds Biosciences
Develops selective serotonin agonists for epilepsy, PWS, and neuropsychiatric disorders.
$72.81
After-hours close−0.11 (−0.15%)
At close$72.92(−2.17%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Aug 2026 | −$1.22 | −$0.17 | +86.1% |
| Aug 2026 | −$1.28 | −$0.17 | +86.8% |
| Aug 2026 | −$1.28 | −$0.17 | +86.8% |
| May 2026 | −$1.17 | −$0.80 | +31.6% |
The latest year is open to everyone — the 24 quarters behind it read with an account. Sign in | |||
| Feb 2026 | |||
| Dec 2025 | |||
| Aug 2025 | |||
| Feb 2025 | |||
| Dec 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Dec 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Dec 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Dec 2021 | |||
| Jul 2021 | |||
| Jun 2021 | |||
| Mar 2021 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Mar 2020 | |||
| Dec 2019 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Aug 17, 2026 | −$1.22 | −$0.17 | +86.1% | — | — | — |
| Aug 14, 2026 | −$1.28 | −$0.17 | +86.8% | — | — | — |
| Aug 13, 2026 | −$1.28 | −$0.17 | +86.8% | — | — | — |
| May 20, 2026 | −$1.17 | −$0.80 | +31.6% | — | — | — |
The latest year is open to everyone — the 24 quarters behind it read with an account. Sign in | ||||||
| Feb 12, 2026 | ||||||
| Dec 23, 2025 | ||||||
| Aug 14, 2025 | ||||||
| Feb 13, 2025 | ||||||
| Dec 30, 2024 | ||||||
| Aug 14, 2024 | ||||||
| May 15, 2024 | ||||||
| Feb 12, 2024 | ||||||
| Dec 29, 2023 | ||||||
| Aug 14, 2023 | ||||||
| May 15, 2023 | ||||||
| Feb 7, 2023 | ||||||
| Dec 29, 2022 | ||||||
| Aug 12, 2022 | ||||||
| May 16, 2022 | ||||||
| Feb 14, 2022 | ||||||
| Dec 29, 2021 | ||||||
| Jul 17, 2021 | ||||||
| Jun 17, 2021 | ||||||
| Mar 31, 2021 | ||||||
| Sep 30, 2020 | ||||||
| Jun 30, 2020 | ||||||
| Mar 31, 2020 | ||||||
| Dec 31, 2019 | ||||||